The Georgia Cancer Center is excited to announce the 2024 RFA for Paceline Awards leading to external funding aligned with NCI designation. Paceline fundraising efforts will support research activities at the Georgia Cancer Center in our mission to reduce the burden of cancer in Georgia and across the globe through superior care, innovation and education.
To this effect, we are calling for proposals that further our mission and support our goal to achieve NCI designation. Eligible research categories include Basic Science, Clinical/Translational, and Population/Health Disparities Research. Each of these categories may be addressed by the following types of projects: PI-Initiated; Early-Career Investigators (Faculty within 7 years of their first time faculty appointment); Multi-PI; and Trainee Mentored Research (for graduate students, postdoctoral fellows, or clinical trainees in conjunction with a mentor). All awards are intended to generate preliminary data (including that for high-risk, high-reward research) to seed competitive, peer-reviewed, external grant applications, leading to the sustained extramural support needed for NCI designation.
Amount: Top-scoring peer-reviewed projects will be eligible to compete for up to $50,000 or $35,000 (Trainees).
Please note New Paceline Requirement: Donate a minimum (personally or via fund raising) of $200 (Faculty applicants) and $20 (Trainee applicants) by December 31, 2025.
Jump to: Subject Categories Project Types Proposal Requirements Eligibility/Criteria
Funding Opportunities Archive
Projects that investigate the etiology of cancer genesis, progression and metastasis or mechanisms of resistance. These studies will generate preliminary data on new areas of research that will lead to the submission of cancer-focused grant proposals to any NIH branch or other agencies that may support NCI designation.
These studies help transition a bench discovery into the clinic or bring back observations from the clinic for further investigation in the lab (e.g., biomarker discovery, research on mechanisms of response or resistance to therapy, physiopathology of unexplained or unexpected complications, etc.). Priority will be given to studies that originate from research performed at the Georgia Cancer Center. Collaborations between laboratory investigators and a clinical investigator are encouraged.
These studies aim to understand or to address cancer in underrepresented populations, specifically in minorities as defined by OMB: The minority racial and ethnic groups defined by OMB are American Indian or Alaska Native, Asian, Black or African American, and Native Hawaiian or other Pacific Islander. The ethnicity used is Latino or Hispanic. Included are studies that aim to understand healthcare disparities and approaches to overcome them. Research related to cancer survivorship is also eligible.
Will propose innovative research that requires teams of investigators with complimentary expertise. The goal of this mechanism is to support Multi-PI projects that can help develop projects that will lead to large multi-PI or program project-like grants. These projects require a 200-word description of the complementary expertise and how the project will lead to externally funded Multi-PI projects in the future. Based on a favorable progress report, these projects may be eligible for a second-year extension. (Maximum budget request $50,000)
1.) Project summary (500 words or less) - Your project summary should consist of a brief background to the problem; hypothesis; clear objectives and specific aims that address the problem; what has already been done regarding this problem; approach (research and design); and the significance of the proposed work.
2.) Cover Page including:
3.) Research Plan (2 pages or less, margins measuring at least 0.5 inch, 11-point Arial font). The description should include:
4.) References (No page Limit)
5.) Budget and justification of expenditures (No page limit)
6.) Other Attachments
